Literature DB >> 23492370

Epithelial mesenchymal transition (EMT) in small airways of COPD patients.

Sukhwinder Singh Sohal, Eugene Haydn Walters.   

Abstract

Entities:  

Keywords:  Airway Epithelium; COPD Pathology

Mesh:

Substances:

Year:  2013        PMID: 23492370      PMCID: PMC3717724          DOI: 10.1136/thoraxjnl-2013-203373

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
We congratulate Milara et al 1 for getting a paper suggesting that epithelial mesenchymal transition (EMT) is important in the pathogenesis of chronic obstructive pulmonary disease (COPD) into a top respiratory journal. This is quite a breakthrough. In the discussion, Milara et al were somewhat dismissive of our findings on EMT markers in large airways of COPD patients;2 commenting that our study was limited by the mesenchymal protein expressions analysed (MMP-9, S100A4, vimentin) being potentially expressed by inflammatory cells. In a follow-up paper3 we excluded such confounding. Further, our study illustrated that cells in the basal epithelium, and reticular basement membrane (Rbm) in smokers/COPD double-stain for cytokeratin-(s) and the ‘EMT marker’ S100A4, confirming a likely epithelial origin of these cells. Notably, Milara et al also stained their tissue with vimentin. The authors also queried the relevance of our findings on larger airways EMT to COPD. A major feature of COPD, in addition to small airway destruction, is its association with lung (airway) cancer. We have found large airway EMT to be associated with increased angiogenesis; this is a process reminiscent of EMT-type 3, a procancer stroma in contrast with the more specifically profibrotic EMT-type-2 which lacks angiogenesis.4–6 Active EMT-type-3 in large airways might be the link between COPD and lung cancer development. For adherens proteins E-cadherin and ZO-1, the authors reported no staining in the smokers/COPD patients’ epithelium, suggesting their expression is lost as the part of EMT. It is true that E-cadherin and ZO-1 epithelial expression does decrease during EMT, but if disappeared completely the epithelium would fall apart. Their protein analysis and immunofluorescence data on primary human bronchial epithelial cells does show E-cadherin and ZO-1 expression, albeit decreased. We have also been looking at small airways in smokers and see a lot of E-cadherin staining but also N-cadherin expression, as another likely expression of EMT (figure 1).
Figure 1

Small airways in surgically resected lung sections from smokers undergoing thoracotomy: (A) black arrows indicating E-cadherin expression in the epithelium; (B) black arrows indicating N-cadherin expression in the epithelium.

Small airways in surgically resected lung sections from smokers undergoing thoracotomy: (A) black arrows indicating E-cadherin expression in the epithelium; (B) black arrows indicating N-cadherin expression in the epithelium. Rbm fragmentation2 which is a vital part of the EMT process4 is evident in the small airway tissue sections shown in the Milara et al paper, as is hypercellularity of the Rbm. However, neither important structural hallmark of EMT is commented upon. The arrows pointing out α-SMA staining, which is below the Rbm, seem to be in the wrong place. In spite of our reservations, this study highlights the potential importance of EMT in COPD, which might change the way we think about this disease process and its nasty clinical consequences.
  5 in total

1.  Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease.

Authors:  Sukhwinder S Sohal; David Reid; Amir Soltani; Chris Ward; Steven Weston; H Konrad Muller; Richard Wood-Baker; Eugene H Walters
Journal:  Respirology       Date:  2010-07-12       Impact factor: 6.424

2.  Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study.

Authors:  Amir Soltani; David W Reid; Sukhwinder S Sohal; Richard Wood-Baker; Steve Weston; H Konrad Muller; E Haydn Walters
Journal:  Respir Res       Date:  2010-07-30

Review 3.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

4.  Distinctive characteristics of bronchial reticular basement membrane and vessel remodelling in chronic obstructive pulmonary disease (COPD) and in asthma: they are not the same disease.

Authors:  Amir Soltani; Hans Konrad Muller; Sukhwinder S Sohal; David W Reid; Steve Weston; Richard Wood-Baker; Eugene Haydn Walters
Journal:  Histopathology       Date:  2012-02-09       Impact factor: 5.087

5.  Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease.

Authors:  Sukhwinder S Sohal; David Reid; Amir Soltani; Chris Ward; Steven Weston; H Konrad Muller; Richard Wood-Baker; E Haydn Walters
Journal:  Respir Res       Date:  2011-10-05
  5 in total
  16 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

Review 2.  Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke.

Authors:  Mari Hikichi; Kenji Mizumura; Shuichiro Maruoka; Yasuhiro Gon
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

3.  Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS.

Authors:  Nirupama Putcha; Ashraf Fawzy; Gabriel G Paul; Allison A Lambert; Kevin J Psoter; Venkataramana K Sidhaye; John Woo; J Michael Wells; Wassim W Labaki; Claire M Doerschuk; Richard E Kanner; MeiLan K Han; Carlos Martinez; Laura M Paulin; Fernando J Martinez; Robert A Wise; Wanda K O'Neal; R Graham Barr; Nadia N Hansel
Journal:  Ann Am Thorac Soc       Date:  2018-06

Review 4.  Extracellular Vesicles as Central Mediators of COPD Pathophysiology.

Authors:  Derek W Russell; Kristopher R Genschmer; J Edwin Blalock
Journal:  Annu Rev Physiol       Date:  2021-11-01       Impact factor: 19.318

5.  mAChRs activation induces epithelial-mesenchymal transition on lung epithelial cells.

Authors:  Kai Yang; Yun Song; Ya-Bing Tang; Zu-Peng Xu; Wei Zhou; Li-Na Hou; Liang Zhu; Zhi-Hua Yu; Hong-Zhuan Chen; Yong-Yao Cui
Journal:  BMC Pulm Med       Date:  2014-03-31       Impact factor: 3.317

6.  A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial-mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept study.

Authors:  Sukhwinder Singh Sohal; Amir Soltani; David Reid; Chris Ward; Karen E Wills; H Konrad Muller; Eugene Haydn Walters
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-05-27

7.  Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD).

Authors:  Sukhwinder Singh Sohal; Eugene Haydn Walters
Journal:  Respir Res       Date:  2013-11-06

8.  Endothelial to mesenchymal transition (EndMT): an active process in Chronic Obstructive Pulmonary Disease (COPD)?

Authors:  Sukhwinder Singh Sohal
Journal:  Respir Res       Date:  2016-02-22

9.  Epithelial mesenchymal transition in smokers: large versus small airways and relation to airflow obstruction.

Authors:  Malik Quasir Mahmood; Sukhwinder Singh Sohal; Shakti Dhar Shukla; Chris Ward; Ashutosh Hardikar; Wan Danial Noor; Hans Konrad Muller; Darryl A Knight; Eugene Haydn Walters
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-08-04

10.  Clinical significance of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD): potential target for prevention of airway fibrosis and lung cancer.

Authors:  Sukhwinder Singh Sohal; Malik Quasir Mahmood; Eugene Haydn Walters
Journal:  Clin Transl Med       Date:  2014-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.